Report from GCAN: Gout, Urate and the repositioning of innate immunity: Dr. Michael Pillinger

Report from GCAN: Gout, Urate and the repositioning of innate immunity: Dr. Michael Pillinger

How FAST can you go? with Dr. Michael PillingerПодробнее

How FAST can you go? with Dr. Michael Pillinger

Gout - causes, symptoms, diagnosis, treatment, pathologyПодробнее

Gout - causes, symptoms, diagnosis, treatment, pathology

Comorbidities in Gout with Dr. Nicola DalbethПодробнее

Comorbidities in Gout with Dr. Nicola Dalbeth

Pipeline Therapies for Urate Lowering: Dr. Michael PillingerПодробнее

Pipeline Therapies for Urate Lowering: Dr. Michael Pillinger

Dr. Ken Saag at ACR 17 on Pegloticase in GoutПодробнее

Dr. Ken Saag at ACR 17 on Pegloticase in Gout

Liming Li's Lab: Investigating Yeast Mechanisms Relating to DiseaseПодробнее

Liming Li's Lab: Investigating Yeast Mechanisms Relating to Disease

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout AttacksПодробнее

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout Attacks

Dr. Daniele on Impact of Regorafenib in HCCПодробнее

Dr. Daniele on Impact of Regorafenib in HCC

OTC Sub $1 Stock The Greater Cannibas Company (GCAN) FallsПодробнее

OTC Sub $1 Stock The Greater Cannibas Company (GCAN) Falls

The ADVOCATE Trial: A Conversation with Dr. Peter A. MerkelПодробнее

The ADVOCATE Trial: A Conversation with Dr. Peter A. Merkel

How can precision medicine improve outcomes in GI oncology?Подробнее

How can precision medicine improve outcomes in GI oncology?

Progress Report II - Tibor Dániel FehérПодробнее

Progress Report II - Tibor Dániel Fehér

TGR5 in inflammation – Video abstract 40102Подробнее

TGR5 in inflammation – Video abstract 40102

GI Cancer: Understanding the Relevant Immune PathwaysПодробнее

GI Cancer: Understanding the Relevant Immune Pathways

Progress Report II - Dénes KovácsПодробнее

Progress Report II - Dénes Kovács

$.016 Penny Stock with a ton of potential!!Подробнее

$.016 Penny Stock with a ton of potential!!

Glomerular Disease Study and Trial ConsortiumПодробнее

Glomerular Disease Study and Trial Consortium

Dr. Glaucomflecken Explains: Pomalidomide for Epistaxis in Hereditary Hemorrhagic TelangiectasiaПодробнее

Dr. Glaucomflecken Explains: Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia